MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Strona główna・Stock List・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Closed

SectorHealthcare

593.27 1.9

Buy Sell

Overview

Share price change

24h

Current

Min

588.3

Max

594.48

Key metrics
By Trading Economics
Income	-72M -114M
Sales	74M 287M
Profit margin	-39.75
Employees	528
EBITDA	-68M -106M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+5.19% upside

Market Stats
By TradingEconomics
Market Cap	4.2B 13B
Previous open	591.37
Previous close	593.27

News Sentiment

By Acuity

34%

66%

58 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

263.2 / 277.1 Support & Resistance

Madrigal Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 sty 2026, 22:45 UTC

Major Market Movers

GH Research Shares Up, Plans to Provide Update on New Drug Application

3 sty 2026, 18:59 UTC

Major News Events

Update: Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 sty 2026, 17:42 UTC

Major News Events

The Oil Sector's Biggest Winners and Losers From Venezuela Regime Change -- Barrons.com

3 sty 2026, 17:40 UTC

Major News Events

Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 sty 2026, 16:10 UTC

Major News Events

What Maduro's Capture Means for Chevron Stock -- Barrons.com

3 sty 2026, 15:53 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 15:03 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 14:10 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 12:16 UTC

Major News Events

U.S. Captures Maduro, Trump Says -- Barrons.com

3 sty 2026, 09:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

3 sty 2026, 09:20 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

3 sty 2026, 00:43 UTC

Acquisitions, Mergers, Takeovers

Research Reports -- Barrons.com

2 sty 2026, 22:13 UTC

Market Talk

Earnings

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 sty 2026, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

2 sty 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 sty 2026, 21:07 UTC

Earnings

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2 sty 2026, 20:09 UTC

Market Talk

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2 sty 2026, 19:48 UTC

Market Talk

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2 sty 2026, 18:53 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 sty 2026, 18:53 UTC

Market Talk

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2 sty 2026, 17:56 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2 sty 2026, 17:50 UTC

Market Talk

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2 sty 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 sty 2026, 16:33 UTC

Market Talk

Remittances to Mexico Fell 5.7% in November -- Market Talk

2 sty 2026, 16:18 UTC

Market Talk

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2 sty 2026, 15:48 UTC

Earnings

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2 sty 2026, 15:17 UTC

Market Talk

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2 sty 2026, 15:01 UTC

Market Talk

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2 sty 2026, 15:00 UTC

Earnings

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2 sty 2026, 14:56 UTC

Market Talk

Tesla's Sales Drop Was Better Than Feared -- Market Talk

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

5.19% upside

12 Months Forecast

Average 624.67 USD 5.19%

High 900 USD

Low 527 USD

Based on 11 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Madrigal Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

263.2 / 277.1Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

58 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.